The time course of tumour responses to immunotherapies can be mathematically predicted on the basis of tumour-growth rates, the rates of immune activation and of tumour–immune-cell interactions, and the efficacy of immune-mediated tumour killing.
References
Ngwa, W. et al. Nat. Rev. Cancer 18, 313–322 (2018).
Postow, M. A. et al. N. Engl. J. Med. 372, 2006–2017 (2015).
Boland, G. M. & Flaherty, K. T. Nat. Cancer 1, 160–162 (2020).
Schwartz, L. H. et al. Eur. J. Cancer 62, 138–145 (2016).
Konstorum, A., Vella, A. T., Adler, A. J. & Laubenbacher, R. C. J. R. Soc. Interface 14, 20170150 (2017).
Butner, J. D. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-020-00662-0 (2021).
Trebeschi, S. et al. Ann. Oncol. 30, 998–1004 (2019).
Butner, J. D. et al. Sci. Adv. 6, eaay6298 (2020).
Sung, W. et al. Radiother. Oncol. 151, 73–81 (2020).
Palma, D. A. et al. Lancet 393, 2051–2058 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Grassberger, C., Ngwa, W. Modelling treatment-response rates. Nat Biomed Eng 5, 295–296 (2021). https://doi.org/10.1038/s41551-021-00717-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-021-00717-w
- Springer Nature Limited